We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+25.53%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$2.84B
AUM Growth
+$360M
Cap. Flow
-$149M
Cap. Flow %
-5.26%
Top 10 Hldgs %
25.12%
Holding
310
New
37
Increased
50
Reduced
189
Closed
10

Top Buys

Rank Stock Value
1
MEDP icon
Medpace
MEDP
+$24.7M
2
ARNA
Arena Pharmaceuticals Inc
ARNA
+$21.7M
3
FOLD
Amicus Therapeutics
FOLD
+$12.1M
4
PBH icon
Prestige Consumer Healthcare
PBH
+$11.6M
5
LGND icon
Ligand Pharmaceuticals
LGND
+$10.8M

Top Sells

Rank Stock Value
1
IMMU
Immunomedics Inc
IMMU
+$51M
2
ETSY icon
Etsy
ETSY
+$38.3M
3
AIMT
Aimmune Therapeutics
AIMT
+$33.6M
4
BSTC
BioSpecifics Technologies Corp.
BSTC
+$19.5M
5
TTD icon
Trade Desk
TTD
+$12.2M

Sector Composition

Rank Sector Weight
1 Healthcare 26.47%
2 Technology 23.43%
3 Industrials 17.34%
4 Consumer Discretionary 13.01%
5 Communication Services 6.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GBT
51
DELISTED
Global Blood Therapeutics, Inc.
GBT
$17M 0.6%
393,415
+72,488
+23% +$3.57M
LKQ icon
52
LKQ Corp
LKQ
$6.29B
$16.9M 0.6%
479,998
+20,303
+4% +$694K
RETA
53
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$16.8M 0.59%
135,828
-37,464
-22% -$4.92M
CSOD
54
DELISTED
Cornerstone OnDemand, Inc.
CSOD
$15.1M 0.53%
343,311
-131,975
-28% -$5.46M
ACAD icon
55
Acadia Pharmaceuticals
ACAD
$5.03B
$14.7M 0.52%
274,159
-820
-0.3% -$40.7K
FOLD
56
DELISTED
Amicus Therapeutics
FOLD
$13.7M 0.48%
+592,532
New +$12.1M
PCOM
57
DELISTED
Points.com Inc. Common Shares
PCOM
$12.5M 0.44%
868,505
+25,413
+3% +$291K
CSGP icon
58
CoStar Group
CSGP
$12.3B
$12.4M 0.44%
134,350
-8,860
-6% -$777K
INSM icon
59
Insmed
INSM
$28.6B
$12M 0.42%
361,850
-120,157
-25% -$4.39M
CNTY icon
60
Century Casinos
CNTY
$34M
$11.3M 0.4%
1,775,195
-20,241
-1% -$117K
ZGNX
61
DELISTED
Zogenix, Inc.
ZGNX
$11M 0.39%
548,648
-11,534
-2% -$236K
KNSA icon
62
Kiniksa Pharmaceuticals
KNSA
$5.93B
$10.6M 0.37%
+599,517
New +$10.5M
NKTR icon
63
Nektar Therapeutics
NKTR
$2.58B
$9.66M 0.34%
37,892
-1,637
-4% -$423K
ALBO
64
DELISTED
Albireo Pharma Inc
ALBO
$9.65M 0.34%
257,372
+170,014
+195% +$6.18M
MSM icon
65
MSC Industrial Direct
MSM
$6.86B
$9.56M 0.34%
113,301
-4,671
-4% -$361K
SWI
66
DELISTED
SolarWinds Corporation Common Stock
SWI
$9.23M 0.32%
585,074
+34,954
+6% +$766K
MIME
67
DELISTED
Mimecast Limited
MIME
$9.12M 0.32%
+160,379
New +$7.41M
CSW
68
CSW Industrials
CSW
$5.71B
$8.87M 0.31%
79,224
+3,544
+5% +$354K
AAP icon
69
Advance Auto Parts
AAP
$3.49B
$8.84M 0.31%
56,136
-3,820
-6% -$589K
UTMD icon
70
Utah Medical Products
UTMD
$225M
$8.77M 0.31%
104,075
+4,628
+5% +$395K
FC icon
71
Franklin Covey
FC
$246M
$8.5M 0.3%
381,773
+5,276
+1% +$110K
LMAT icon
72
LeMaitre Vascular
LMAT
$1.86B
$8.43M 0.3%
208,051
+168,188
+422% +$6.01M
NBIX icon
73
Neurocrine Biosciences
NBIX
$16.6B
$8.35M 0.29%
87,118
+12,938
+17% +$1.25M
PEGA icon
74
Pegasystems
PEGA
$5.38B
$8.28M 0.29%
124,328
-37,684
-23% -$2.4M
MODV
75
DELISTED
ModivCare
MODV
$7.9M 0.28%
57,013
+24,771
+77% +$3.07M
1 2
3
4 5

Similar funds

WFMPM
Woodley Farra Manion Portfolio Management Indianapolis, Indiana $2.05B AUM 14.54% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
HBT
Hills Bank & Trust North Liberty, Iowa $2.07B AUM 13.46% 1-Year Est. Return
IL
Investure LLC Charlottesville, Virginia $2.04B AUM 15.91% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
SW
SoFi Wealth San Francisco, California $2.08B AUM 18.22% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return

Rice Hall James & Associates's Q4 2020 Portfolio in Review

As of Q4 2020, Rice Hall James & Associates held 310 positions worth $2.84B, up 15% from $2.48B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Rice Hall James & Associates withdrew a net $149M in Q4 2020, closing 10 positions and reducing 189 holdings. Its most notable exit was Immunomedics Inc, an estimated $51M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 25% a quarter earlier, followed by Technology and Industrials.

Against the trend, Rice Hall James & Associates opened a new position in Medpace worth $27.3M.

  • Rice Hall James & Associates's largest Q4 2020 buy was Medpace: 195,984 shares worth $27.3M.
  • Rice Hall James & Associates added most to Prestige Consumer Healthcare in Q4 2020, an estimated $11.6M increase.
  • Rice Hall James & Associates's biggest Q4 2020 reduction was Etsy, cutting an estimated $38.3M.
  • Rice Hall James & Associates fully exited Immunomedics Inc in Q4 2020, selling an estimated $51M.
  • Rice Hall James & Associates's ten largest holdings make up 25% of its $2.84B portfolio in Q4 2020.
  • Rice Hall James & Associates opened 37 new positions and closed 10 in Q4 2020.
  • Rice Hall James & Associates's portfolio value rose 15% quarter-over-quarter to $2.84B.

Based on Rice Hall James & Associates's 13F filing for Q4 2020, filed 16 Feb 2021.